Overview

CEP-701 for PH-negative Myelofibrosis

Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to find out if CEP-701 can help control myelofibrosis (MF). The safety of CEP-701 will also be studied.
Phase:
Phase 2
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborator:
Cephalon